One of the most damaging allegations included in the Wall Street Journal's exposè of the company published on Sunday night was that two years ago Theranos deleted quality-control records to make the data from its proprietary machines appear to be more accurate. That type of alleged tampering is so serious because it represents a breach of scientific integrity and is almost unheard of in the biotech industry, legal experts tell Fast Company.
Read Full Article »
